Semaglutide has rapidly become one of the most discussed medications for weight management and type 2 diabetes, raising important questions about its safety in pregnancy. People who are pregnant or planning pregnancy want clear, evidence-based answers about whether semaglutide causes birth defects.
Below you will find a detailed overview of current data, labeled pregnancy registries, and practical guidance for people who are or may become pregnant while using this medication.
| Outcome | Observed Risk with Semaglutide | Background General Risk | Key Source |
|---|---|---|---|
| Major congenital malformations | Limited human data; ongoing registries collecting evidence | 2–4% in general population | Healthcare provider labeling, FDA pregnancy registries |
| Miscarriage | Not established; observational data mixed | 10–15% clinically recognized pregnancies | Observational studies, product information |
| Preterm birth | Data limited; some signals under investigation | About 10% in many populations | Pharmacologic cohort studies |
| Fetal growth concerns | Potential small-for-gestational-age signals, not confirmed | Variable by population | Pregnancy exposure registries |
Semaglutide Use in Early Pregnancy
During the first trimester, organogenesis occurs, making this period especially sensitive to medication exposures. Semaglutide has structural similarities to other GLP-1 receptor agonists, and clinicians rely on pregnancy registries and pharmacologic class information when advising people who are or may become pregnant. Decisions about continuation or discontinuation should consider glycemic control benefits for both parent and fetus.
Semaglutide Use in Later Pregnancy
Data on the effects of semaglutide during the second and third trimesters are very limited. Because rapid fetal growth and metabolic programming occur later in pregnancy, healthcare providers weigh potential maternal and fetal risks carefully. If semaglutide is continued into later pregnancy, closer monitoring of fetal growth and amniotic fluid volume is commonly recommended.
Weight and Diabetes Management Alternatives
For people with obesity or type 2 diabetes who are pregnant or planning pregnancy, alternatives to semaglutide may include lifestyle modifications, insulin, and metformin, depending on clinical context. These options have longer safety histories in pregnancy, though individual risk and benefit profiles differ. Shared decision-making with an obstetrician, endocrinologist, and primary care clinician helps align treatment with personal health goals.
Semaglutide Pregnancy Exposure and Safety Data
Real-world and registry data are evolving, but current evidence does not definitively establish whether semaglutide causes birth defects. Ongoing studies aim to clarify risks for structural anomalies, pregnancy loss, and neonatal outcomes. Until more evidence is available, guidelines emphasize using the lowest effective dose and avoiding unnecessary exposures during organogenesis.
Key Recommendations for People Considering Pregnancy
- Discuss family planning with your healthcare team before starting or continuing semaglutide.
- Use effective contraception while taking semaglutide if you are not trying to conceive.
- If pregnancy occurs, seek medical guidance promptly to evaluate medication options.
- Consider enrolling in a pregnancy exposure registry to support ongoing safety research.
FAQ
Reader questions
Can I continue semaglutide if I find out I am pregnant?
Many clinicians recommend stopping semaglutide as soon as pregnancy is confirmed and switching to a medication with a better-established safety profile in pregnancy, such as insulin, after discussing risks and benefits with your healthcare team.
Will taking semaglutide while pregnant cause birth defects in my baby?
There is no conclusive evidence that semaglutide causes birth defects in humans, but because animal studies show some fetal risks, experts advise caution and close monitoring until more data are available from pregnancy registries.
What should I do if I was on semaglutide and became pregnant?
Contact your healthcare provider promptly to review your individualized risks and benefits, discuss alternative diabetes and weight management options, and consider enrolling in a pregnancy exposure registry to contribute to safety data.
Could semaglutide affect my baby after birth through breastfeeding?
It is not known whether semaglutide passes into breast milk or affects milk production, so many clinicians advise against breastfeeding while using this medication or switching to a compatible alternative if necessary.